English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduDogs infected with echinococcosis play a major role in spreading tapeworms across human populations around the world. Now, researchers have developed a “smart collar” which gradually delivers a steady dose of a deworming drug to dogs. The collar successfully reduces…
Tag: INFECTIOUS/EMERGING DISEASES
Packaged water consumption linked to cholera outbreak in DRC capital
Cholera is a diarrheal disease caused by ingestion of the Vibrio cholerae bacterium. In November 2017, a cholera epidemic occurred in Kinshasa, the Democratic Republic of the Congo, where no outbreak had been recorded for nearly a decade. A study…
Arab participation in global genomic study could lead to new therapies for COVID patients
Researchers from Qatar Foundation Research, Development, and Innovation’s Qatar Genome Programme contribute toward global initiative that can lead to therapeutic targets in addition to the protection conferred by the vaccines
The Lancet: CoronaVac COVID-19 vaccine is safe and protects against disease, interim analysis
Interim data from a phase 3 trial of a COVID-19 vaccine developed in China (CoronaVac) suggests that two doses offer 83.5% protection against symptomatic COVID-19. The preliminary findings, published in The Lancet and presented at this year’s European Congress of…
Inhaled COVID-19 vaccine prevents disease and transmission in animals
In a new study assessing the potential of a single-dose, intranasal COVID-19 vaccine, a team from the University of Iowa and the University of Georgia found that the vaccine fully protects mice against lethal COVID-19 infection. The vaccine also blocks…
Biomaterial vaccines ward off broad range of bacterial infections and septic shock
A new vaccine technology combining capture of bacterial pathogens with effective immune-reprogramming biomaterials could be applied to a broad spectrum of infectious diseases
A summary of myocarditis cases following COVID-19
Myocarditis-or inflammation around the heart–has been reported in some patients with COVID-19. After searching the medical literature, researchers have now summarized the results of 41 studies describing myocarditis in 42 patients with COVID-19. The analysis, which is published in the…
Has the COVID-19 pandemic lessened bullying at school?
Students reported far higher rates of bullying at school before the COVID-19 pandemic than during the pandemic across all forms of bullying–general, physical, verbal, and social–except for cyber bullying, where differences in rates were less pronounced. The findings come from…
Instant COVID sensor to prevent outbreaks and protect communities
Sensor detects COVID-19 and variants on people’s breath, even when they are asymptomatic
Repurposed drugs present new strategy for treating COVID-19
Virtual screening of 6,218 drugs and cell-based assays identifies best therapeutic medication candidates
Highly fit teenagers coped better with COVID-19 later in life
Of the Swedish men in their late teens who performed well in the physical fitness tests for military conscription, a relatively high proportion were able to avoid hospital care when they became infected with COVID-19 during the pandemic up to…
Mapping Dengue Hot Spots Pinpoints Risk for Zika and Chikungunya
Data from nine cities in Mexico confirms that identifying dengue fever “hot spots” can provide a predictive map for future outbreaks of Zika and chikungunya. All three of these viral diseases are spread by the Aedes aegypti mosquito.
New study shows mathematical models helped reduce the spread of COVID-19
Colorado researchers have published new findings in Emerging Infectious Diseases that take a first look at the use of SARS-CoV-2 mathematical modeling to inform early statewide policies enacted to reduce the spread of the Coronavirus pandemic in Colorado.
Wolbachia and the paradox of growth regulation
A genetic approach offers new clues to the regulation of Wolbachia proliferation and the effect of over-proliferation on the insect hosts.
Mount Sinai research reveals how Ebola virus manages to evade the body’s immune defenses
New York, NY (July 6, 2021) – Mount Sinai researchers have uncovered the complex cellular mechanisms of Ebola virus, which could help explain its severe toll on humans and identify potential pathways to treatment and prevention. In a study published…
Commensal bacteria ‘vaccine’ may safely prep immune cells for meningitis-causing cousin
Researchers have produced vaccine-like immune responses to a dangerous bacterium by colonizing 26 healthy volunteers with a related, but harmless, commensal bacterial species. The first-in-human, controlled infection study showed the strategy was safe, as no side effects were reported and…
‘Fortunate accident’ may yield immunity weapon against antibiotic-resistant bacteria
Johns Hopkins Medicine study uncovers enzyme inhibitor that boosts immune system to fight MRSA and other dangerous skin infections
Prolonged physiological, behavioral changes associated with COVID-19 infection
What The Study Did: W earable sensor data were used to examine the duration and variation of recovery among COVID-19-positive and COVID-19-negative participants. Authors: Jennifer M. Radin, Ph.D., M.P.H., of the Scripps Research Translational Institute in La Jolla, California, is…
Study: Hospitals not adequately prepared for next pandemic
Use of new preparedness tool can help hospitals determine their ability to respond to unexpected surges due to mass shootings, terrorist attacks, or future pandemics
Study shows laboratory developed protein spikes consistent with COVID-19 virus
A new international study has found that the key properties of the spikes of SARS-CoV-2 virus which causes COVID-19 are consistent with those of several laboratory-developed protein spikes, designed to mimic the infectious virus.
Fighting COVID with COVID
Researchers design new COVID-19 therapy that uses a defective version of the SARS-CoV-2 virus to drive the disease-causing version to extinction
Eight new studies to investigate COVID-19 variants of concern in Canada
The research projects span from investigating the social factors that may protect Indigenous peoples — or increase their vulnerability to — COVID-19 and VOCs, to the creation of a Canadian Wastewater Surveillance Database
Do heart medications affect COVID-19 outcomes?
Cardiovascular drugs do not affect COVID-19 outcomes–such as disease severity, hospitalizations, or deaths–according to an analysis of all relevant studies published as of November 2020. The findings are published in the British Journal of Clinical Pharmacology . Investigators included 429…
SARS-CoV-2 encoded miRNA is a biomarker for stratification of severe patients
In a retrospective, multi-centre cohort study conducted by researchers from Nanjing University, Huazhong University of Science and Technology, Jinling Hospital and the Second Hospital of Nanjing, a microRNA-like small RNA encoded by SARS-CoV-2 was identified in the serum of COVID-19…
Epsilon variant mutations contribute to COVID immune evasion
Studies reveal unprecedented mechanism behind loss of antibody neutralization against this pandemic coronavirus variant of concern
Significant increase in impact factor ratings for Bentham Science journals
Clarivate has recently published the latest edition of Journal Citation Reports® providing information for the category ranking and Impact Factor ratings of the indexed journals in 2020. Bentham Science journals have performed well and received outstanding Impact Factor rankings this…
Novel coronavirus infects and replicates in salivary gland cells
A study conducted at the University of São Paulo suggests that tissues specializing in saliva production and secretion serve as reservoirs for SARS-CoV-2, magnifying its infectious potential.
Diabetes care, glycemic control during pandemic in US
What The Study Did: R ates at which patients with type 2 diabetes received diabetes-related health services prior to and during the COVID-19 pandemic are compared in this study. Authors: Ateev Mehrotra, M.D., M.P.H., of Harvard Medical School in Boston,…
Evaluation of messenger RNA from COVID-19 vaccines in human milk
What The Study Did: COVID-19 v accine-associated messenger RNA (mRNA) wasn’t detected in 13 human milk samples collected after vaccination from seven breast feeding mothers. Authors: Stephanie L. Gaw, M.D., Ph.D., of the University of California, San Francisco, is the…
Seroprevalence, risk factors associated with SARS-CoV-2 infection in health care workers in Italy early in pandemic
What The Study Did: This study in the Lombardy region of Italy examined the association of different health care professional categories and operational units, including in-hospital wards and outpatient facilities, with the seroprevalence of positive IgG antibody tests for SARS-CoV-2…
Interleukin-6 antagonists improve outcomes in hospitalised COVID-19 patients
Findings from a study published today [6 July] in the Journal of the American Medical Association ( JAMA ) have prompted new World Health Organization (WHO) recommendations to use interleukin-6 antagonists in patients with severe or critical COVID-19 along with…
Setting COVID-19 drug trials up for success
Clinical studies of COVID-19 drugs may benefit from randomization and early recruitment, model shows
Sixth Joint Science Conference of the Western Balkans Process
10 Point Plan to control coronavirus pandemic in the region
AID/APOBECs among important factors in body’s defence against SARS-CoV-2
A MedUni Vienna research team has now addressed the potential interrelations between AID/APOBECs and the SARS-CoV-2
Infusion centers associated with substantially better outcomes than the ER for patients with acute pain events and sickle cell disease
Embargoed news from Annals of Internal Medicine
Kansas State University virologists publish new findings on SARS-CoV-2 treatment option
MANHATTAN, KANSAS — A recent study by Kansas State University virologists demonstrates successful postinfection treatment for SARS-CoV-2, the virus that causes COVID-19. College of Veterinary Medicine researchers Yunjeong Kim and Kyeong-Ok “KC” Chang published the study in the prestigious journal…
Researchers find potential path to a broadly protective COVID-19 vaccine using T cells
Using a method developed for HIV, researchers have identified stable T cell vaccine targets in SARS-CoV-2
Only 20 states used health equity committees in COVID-19 vaccine distribution planning
New analysis finds that despite major COVID-19 health disparities, fewer than half of US states included health equity committees in vaccine distribution plans, and only 8 included representatives from minority groups
Lottery-based incentives do not increase COVID-19 vaccination rates
(Boston)–Would you be more willing to get vaccinated against the COVID-19 virus if you could participate in a lottery for cash and prizes? The answer was surprisingly no, according to Boston University School of Medicine (BUSM) researchers who found that…
Inside the lungs, a new hope for protection against flu damage
New experimental data pinpoints a molecular component responsible for modulating the damage the flu can wreck on the lungs
Evaluation of health equity in COVID-19 vaccine distribution plans in US
What The Study Did: Researchers in this study aimed to determine how each state and the District of Columbia planned to ensure equitable COVID-19 vaccine distribution. Authors: Juan C. Rojas, M.D., of the University of Chicago, is the corresponding author.…
Women’s use of preventive health services during COVID-19
What The Study Did: Changes in the use of women’s preventive health services during the COVID-19 pandemic, including screening for sexually transmitted infections, breast and cervical cancer, and obtaining contraceptives from pharmacies are described by researchers in this study. Authors:…
94% of patients with cancer respond well to COVID-19 vaccines
Small subsets of high-risk patients produce few or no antibodies, however
Leaders’ pandemic policies engendered varying levels of trust
As the COVID-19 pandemic exploded across the globe in early 2020, the world’s leaders were faced with a flurry of tough moral dilemmas. Should schools and businesses shut down, and if so, for how long? Who should receive scarce resources,…
Study with healthcare workers supports that immunity to SARS-CoV-2 is long-lasting
Despite a large heterogeneity in Spike-specific antibody levels, most individuals remain seropositive for at least one year after infection
Hi-tech lab to boost COVID-19 diagnostic capability, prepare for future pandemics
Singapore, 1 July 2021 – Nanyang Technological University, Singapore (NTU Singapore) and Pathnova Laboratories, a medical diagnostic company backed by Temasek Life Sciences Accelerator and headquartered in Temasek Life Sciences Laboratory, is contributing to Singapore’s COVID-19 diagnostic capability through its…
FAPESP webinar will discuss how SARS-COV-2 affects the human brain
Renowned scientists will focus on COVID’s impact on the human brain addressing molecular mechanisms from both cellular and organismal viewpoints
Chasing the cells that predict death from severe COVID-19
Gladstone scientists have uncovered T-cell signatures that may help understand why some people succumb to severe COVID-19 while others recover
SARS-CoV-2 replication targets nasal ciliated cells early in COVID-19 infection
The establishment of nasal mucosal immunity against SARS-CoV-2 through a nasal vaccine could be the most efficient way to combat COVID-19 infection
Mefloquine: A promising drug ‘soldier’ in the battle against COVID-19
Scientists propose the repurposing of anti-malarial drug mefloquine to fight the novel coronavirus